Dihydromyricetin mitigates epilepsy and cognitive impairment via NLRP3 inhibition in rats

Dihydromyricetin mitigates epilepsy and cognitive impairment via NLRP3 inhibition in rats

Saved in:

Bibliographic Details
Main Authors:	Qing Li, Zhenzhen Qu, Zhuofeng Mao, Lijing Jia, Qi Qiao, Yange Zhang, Kaiping Zhou, Liqin Che, Weiping Wang
Format:	Article
Language:	English
Published:	Termedia Publishing House 2025-04-01
Series:	Folia Neuropathologica
Subjects:	epilepsy nlrp3 inflammasome dihydromyricetin cognition hippocampus
Online Access:	https://www.termedia.pl/Dihydromyricetin-mitigates-epilepsy-and-cognitive-impairment-via-NLRP3-inhibition-in-rats,20,55948,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hippocampal NLRP1 inflammasome mediates anxiety-like behavior in mice with hypothyroidism
by: Yu-Wei Cheng, et al.
Published: (2025-05-01)

NLRP3 inflammasome inhibits mitophagy during the progression of temporal lobe epilepsy
by: Mengqian Wu, et al.
Published: (2025-05-01)

Probiotic Bifico Ameliorates Depression- and Anxiety-Like Behaviors Induced by Estrogen Deficiency via NLRP3 Inflammasome Inhibition
by: Yu X, et al.
Published: (2025-06-01)

Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice
by: Fei Teng, et al.
Published: (2025-12-01)

JC124 confers multimodal neuroprotection in epilepsy by suppressing NLRP3 inflammasome activation: evidence from animal and human neuronal models
by: Peng Zhang, et al.
Published: (2025-07-01)

Downregulation of the HCN1 Channel Alleviates Anxiety‐ and Depression‐Like Behaviors in Mice With Cerebral Ischemia–Reperfusion Injury by Suppressing the NLRP3 Inflammasome
by: Mei Zhou, et al.
Published: (2025-04-01)

Does dihydromyricetin protect the kidney following ischemia–reperfusion injury in male rats?
by: Fayez T. Hammad, et al.
Published: (2025-06-01)

MDA-MB-231 cell apoptosis in vitro induced by dihydromyricetin
by: ZHOU Fang-zhen, et al.
Published: (2012-05-01)

NLRP12-associated periodic syndrome: A description of the authors' own observation and an analysis of literature data
by: M. F. Dubko, et al.
Published: (2017-04-01)

NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria
by: Mateusz Szczerba, et al.
Published: (2025-05-01)

Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia
by: Adnan Akif, et al.
Published: (2025-06-01)

Protective effects of dihydromyricetin against radiation-induced injury to the hematopoietic system
by: Xiao Sun, et al.
Published: (2025-06-01)

NOD2-NLRP3 Axis and Asthma
by: Cai X
Published: (2025-05-01)

Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations
by: Mengxue Wang, et al.
Published: (2025-05-01)

Structural Characterization and Bioactivity Evaluation of Selenium-Modified Dihydromyricetin from Vine Tea
by: Kaixuan Cheng, et al.
Published: (2025-05-01)

Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria
by: Alvaro González‐Dominguez, et al.
Published: (2021-08-01)

Effect of experimental gestational diabetes and administration of glibenclamide on mRNA level of NLRP3-inflammasome and distribution of NLRP3+-cells in mesenteric lymph nodes in progeny
by: Т. М. Prozorova, et al.
Published: (2017-08-01)

Influence of the Maillard Reaction on the Properties of Gelatin/Zein Nanofibers Loaded with Dihydromyricetin Prepared by Electro-Blowing Spinning
by: Hui Xiang, et al.
Published: (2025-06-01)

Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)

Dihydromyricetin/Protein Pickering Emulsions: Interfacial Behavior, Rheology, and <i>In Vitro</i> Bioaccessibility
by: Shengqi Mei, et al.
Published: (2025-07-01)

Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
by: Yao Jun, et al.
Published: (2024-12-01)

Zein-Gum Arabic Loaded with Dihydromyricetin: Preparation and Analysis of Nanoparticles
by: Dawei CHANG, et al.
Published: (2025-06-01)

Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders
by: Yike Zhang, et al.
Published: (2025-07-01)

NLRP3 inflammasome: a key player in neonatal brain injury
by: Cagla Kiser, et al.
Published: (2025-07-01)

UFMylation of NLRP3 Prevents Its Autophagic Degradation and Facilitates Inflammasome Activation
by: Jiongjie Jing, et al.
Published: (2025-04-01)

Molecular hydrogen mitigates traumatic brain injury-induced lung injury via NLRP3 inflammasome inhibition
by: Lingling Liu, et al.
Published: (2025-05-01)

Research and progress of cGAS/STING/NLRP3 signaling pathway: a mini review
by: Ke-qian Chen, et al.
Published: (2025-05-01)

Enhancement of in vitro digestive properties of silver carp (Hypophthalmichthys olivaceus) surimi gels by oxidized dihydromyricetin
by: Qianhui Yu, et al.
Published: (2025-06-01)

Molecular Mechanism of NLRP3 Inflammasome in Inflammatory Diseases and Tumors
by: Le‐Lan Gong, et al.
Published: (2025-07-01)

Salmonella-NLRP3 Inflammasome Crosstalk: Host Defense Activation Versus Bacterial Immune Evasion Strategies
by: Li Y, et al.
Published: (2025-04-01)

Enhanced Cardiomyocyte NLRP3 Inflammasome‐Mediated Pyroptosis Promotes d‐Galactose–Induced Cardiac Aging
by: Wen‐bin Liu, et al.
Published: (2024-07-01)

Dihydromyricetin alleviates ETEC K88-induced intestinal inflammatory injury by inhibiting quorum sensing-related virulence factors
by: Yaqian Shi, et al.
Published: (2025-04-01)

Inhibition of RACK1‐Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress Syndrome
by: Jian Cui, et al.
Published: (2025-07-01)

Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer
by: Zicheng Guo, et al.
Published: (2025-07-01)

NOX2/NLRP3-Inflammasome-Dependent Microglia Activation Promotes As(III)-Induced Learning and Memory Impairments in Developmental Rats
by: Linlin Zhang, et al.
Published: (2025-06-01)

NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)

NLRP3 deficiency abrogates silica-induced neutrophil infiltration, pulmonary damage and fibrosis
by: Maggie Lam, et al.
Published: (2025-03-01)

Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01)

Comparison of Different Keratinocyte Cell Line Models for Analysis of NLRP1 Inflammasome Activation
by: Tian Wang, et al.
Published: (2024-11-01)

Naringin mitigates experimental autoimmune prostatitis by modulating oxidative stress and the NLRP3 inflammasome via the PPAR-γ/NF-κB pathway
by: Wang Zhou, et al.
Published: (2025-07-01)